Anthony Digiandomenico, Director at Provention Bio, Inc. (PRVB), bought 20,000 shares at $10.96 ($219K) on 2019-06-20, disclosed to the SEC on 2019-06-20.
Open-market purchase of $219k PRVB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.96 | 10,000 | $110K | 50.0% |
| 2 | $10.96 | 10,000 | $110K | 50.0% |
| Total | $10.96 avg | 20,000 | $219K | 100% |
| Filing → |
| MDBH | BUY | 2025-02-14 | $8K | — | Filing → |
| MDBH | BUY | 2025-02-11 | $12K | — | Filing → |
| MDBH | BUY | 2025-02-06 | $4K | — | Filing → |